Fate Therapeutics Inc Share Price Today: Live Updates & Key Insights
Fate Therapeutics Inc share price today is $2.41, up -4.37%. The stock opened at $2.52 against the previous close of $2.52, with an intraday high of $2.54 and low of $2.4.
Fate Therapeutics Inc Share Price Chart
Fate Therapeutics Inc
Fate Therapeutics Inc Share Price Performance
Fate Therapeutics Inc Institutional Holdings
Fate Therapeutics Inc Market Status
Fate Therapeutics Inc Fundamentals
Market Cap 293.73 M
PB Ratio 1.6734
PE Ratio 0.0
Enterprise Value 202.69 M
Total Assets 318.94 M
Volume 1044435
Fate Therapeutics Inc Company Financials
About Fate Therapeutics Inc & investment objective
Company Information Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 161
Industry Biotechnology
CEO Dr. Bahram Valamehr M.B.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Fate Therapeutics Inc FAQs
What is the share price of Fate Therapeutics Inc today?
The current share price of Fate Therapeutics Inc is $2.41.
Can I buy Fate Therapeutics Inc shares in India?
Yes, Indian investors can buy Fate Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Fate Therapeutics Inc shares in India?
You can easily invest in Fate Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Fate Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Fate Therapeutics Inc.
Can I buy fractional shares of Fate Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Fate Therapeutics Inc?
Fate Therapeutics Inc has a market cap of $293.73 M.
In which sector does Fate Therapeutics Inc belong?
Fate Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Fate Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Fate Therapeutics Inc?
The PE ratio of Fate Therapeutics Inc is N/A and the PB ratio is 1.67.